FINAL SHAREHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Paragon 28, Inc. (NYSE: FNA) Stockholder Buyout and Encourages Investors to Contact the Firm

1. Kaskela Law is investigating Paragon's buyout by Zimmer Biomet. 2. Paragon shareholders could receive $13.00 per share plus a CVR of $1.00. 3. Concerns arise over whether the buyout price meets shareholder expectations. 4. Analysts previously set price targets above $15.00 for Paragon's shares. 5. Investigation may imply potential breaches of fiduciary duties by Paragon's management.

M&A

75

4m saved

Insight

Article

FAQ

Why Bearish?

The buyout price is lower than analyst targets, indicating potential undervaluation. Historical instances, like recent mergers with similar concerns, have led to stock declines pre-closure.

How important is it?

The investigation signifies possible legal complications affecting share value amidst merger news.

Why Short Term?

The investigation might create uncertainty in the immediate term, affecting stock performance. Past examples suggest market reactions occur swiftly to potential legal issues in M&A.

Related Companies

ZBH AVNS HCA

PHILADELPHIA, March 27, 2025 /PRNewswire/

Kaskela Law LLC announces that it is investigating the recently announced buyout of Paragon 28, Inc. ("Paragon") (NYSE: FNA) shareholders.

Click here for additional information.

On January 28, 2025, Paragon announced that it had agreed to be acquired by Zimmer Biomet Holdings, Inc. ("Zimmer") at an upfront price of $13.00 per share in cash plus a non-tradable contingent value right (CVR) worth up to an additional $1.00 in cash upon the achievement of certain milestones. Following the closing of the proposed transaction, Paragon's shareholders will be cashed out of their investment position and the company's shares will no longer be publicly traded.

The investigation seeks to determine whether Paragon's shareholders will be receiving sufficient monetary consideration for their shares, and whether the company's officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to the $13.00 per share buyout price. Notably, at the time the proposed transaction was announced, several stock analysts were maintaining price targets for the company's shares at or above $15.00 per share.

Paragon shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options.

Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser): https://kaskelalaw.com/case/paragon-28/

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

CONTACT:

KASKELA LAW LLC

D. Seamus Kaskela, Esq. ([email protected])

Adrienne Bell, Esq. ([email protected])

18 Campus Blvd., Suite 100

Newtown Square, PA 19073

(484) 229 – 0750

www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE Kaskela Law LLC